A 74-year-old patient had recurring symptoms of stiffness, weakness and fatigue and required higher doses of prednisone to achieve relief. Alexandra Villa-Forte, MD, presents a case of polymyalgia rheumatica.
Is checkpoint inhibitor-related polymyalgia rheumatica (PMR) distinct from the classic rheumatic disease, or does it represent new clinical variants with potentially different pathogenesis, clinical course and treatment responsiveness? Rheumatologist/immunologist Cassandra Calabrese, DO, discusses her research, which identified clinical features that are unusual in idiopathic PMR.
A rheumatologist discusses the differential diagnosis and treatment of polymyalgia rheumatica and its close cousin, giant cell arteritis.